NCT06416969View on ClinicalTrials.gov

Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

April 1, 2027

Study Completion Date

April 1, 2027

Conditions

Obesity

Interventions

DRUG

Somatostatin

Intravenous infusion 200 ug/hr for 2 hours, 100 ug/hr for 30 minutes

DRUG

Epinephrine

Intravenous infusion

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Mayo Clinic

OTHER

NCT06416969 - Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation | Biotech Hunter | Biotech Hunter